🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, asserting the companies hid safety concerns that the drug created to children's neurological development.

The court filing comes four weeks after President Donald Trump advocated an unverified association between consuming acetaminophen - also known as acetaminophen - throughout gestation and autism in children.

The attorney general is filing suit against J&J, which once produced the drug, the sole analgesic suggested for pregnant women, and Kenvue, which now manufacturers it.

In a declaration, he said they "deceived the public by profiting off of discomfort and marketing drugs without regard for the risks."

The manufacturer says there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These companies lied for decades, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, declared.

Kenvue commented that it was "seriously troubled by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the health of US mothers and children."

On its website, the company also stated it had "consistently assessed the applicable studies and there is insufficient valid information that shows a proven link between using paracetamol and autism."

Organizations speaking for physicians and medical practitioners concur.

The leading OB-GYN organization has declared acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to manage pain and elevated temperature, which can pose major wellness concerns if left untreated.

"In over twenty years of studies on the utilization of acetaminophen in pregnancy, no reliable research has definitively established that the consumption of acetaminophen in any stage of gestation results in brain development issues in offspring," the group stated.

The lawsuit cites recent announcements from the previous government in claiming the drug is potentially dangerous.

In recent weeks, Trump raised alarms from public health officials when he told women during pregnancy to "resist strongly" not to consume acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that physicians should consider limiting the use of Tylenol, while also mentioning that "a causal relationship" between the medication and autism in children has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had vowed in April to initiate "a massive testing and research effort" that would establish the source of autism in a matter of months.

But experts warned that finding a unique factor of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of genetic and external influences - would prove challenging.

Autism is a form of enduring cognitive variation and condition that impacts how people experience and interact with the world, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - aligned with the former president who is seeking US Senate - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

The case attempts to require the firms "remove any commercial messaging" that asserts Tylenol is safe for expectant mothers.

This legal action echoes the concerns of a assembly of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in 2022.

A federal judge dismissed the lawsuit, saying studies from the parents' expert witnesses was lacking definitive proof.